TMO
Thermo Fisher Scientific Inc.
NYQ
$482.08
-11.96
(-2.42%)
Neutral · +0.89σ
Grade C
Quarterly financials
last 5 quarters| Quarter | Revenue | Gross profit | Op income | Net income | Free cash flow | Gross % | Op % | Net % |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $11.01B | $4.43B | $1.91B | $1.65B | $816.0M | 40.3% | 17.4% | 15.0% |
| 2025-12-31 | $12.21B | $5.01B | $2.30B | $1.96B | $2.99B | 41.0% | 18.9% | 16.1% |
| 2025-09-30 | $11.12B | $4.58B | $2.08B | $1.62B | $1.83B | 41.2% | 18.7% | 14.5% |
| 2025-06-30 | $10.85B | $4.41B | $1.92B | $1.62B | $1.10B | 40.6% | 17.7% | 14.9% |
| 2025-03-31 | $10.36B | $4.24B | $1.81B | $1.51B | $361.0M | 40.9% | 17.5% | 14.5% |